- Case report
- Open Access
- Open Peer Review
Cutaneous infection by Mycobacterium haemophilum and kansasii in an IgA-deficient man
© Bekou et al; licensee BioMed Central Ltd. 2011
- Received: 16 March 2010
- Accepted: 26 January 2011
- Published: 26 January 2011
The prevalence of infections by nontuberculous mycobacteria (NTM) has steadily increased over the past decades, especially in immunocompromised patients.
We present a patient with IgA-deficiency and mixed cutaneous infection by two slowly growing mycobacteria, Mycobacterium (M.) haemophilum and M. kansasii.
Cutaneous M. haemophilum infections most often result from HIV or transplantation-associated immunosuppression. Rarely, M. haemophilum may also infect healthy patients or iatrogenically immunosuppressed patients without transplantation. M. kansasii is one of the most frequent NTM and large awareness exists about its involvement in human diseases. Mycobacterial diagnosis of cutaneous infections should be considered in long-lasting skin lesions.
- Atopic Dermatitis
- Carpal Tunnel Syndrome
- Nontuberculous Mycobacterium
- Cutaneous Infection
Immunoglobulin (Ig) A-deficiency is the most common primary antibody deficiency. Although the majority of affected individuals have no apparent symptoms, selected patients suffer from recurrent mucosal infections, allergies, and autoimmune diseases . So far, in patients with selective IgA deficiency no infections with nontuberculous mycobacteria (NTM) have been reported. However, in the last decade NTM are increasingly recognized as infective agents, particularly among immunocompromised patients.
Mycobacterium haemophilum is an established cause of cutaneous infections in immunocompromised hosts . The most common clinical manifestation of M. haemophilum infections are skin lesions with a preference for cooler body sites such as extremeties, while the development of sporotrichoid-like nodular lymphangitis is exceptional.
M. kansasii is one of the most frequent NTM causing human diseases among both immunocompetent and immunocompromised patients . M. kansasii most likely causes infections resembling tuberculosis likewise with a preference for pulmonary disease . Cutaneous infections due to this slow growing mycobacterium are rare and may resemble cellulitis or sporotrichosis. Nevertheless, M. kansasii should be included in the differential diagnosis of skin infections with an indolent course and lack of response to standard antibiotics . Since NTM are typically ubiquitous in the natural environment several routes of transmission may be considered . Unfortunately, the environmental source of M. haemophilum is still unknown, while tap water is likely the major reservoir for M. kansasii infections. Inoculation of NTM into the host usually occurs due to impairment of the physical skin barrier. Affected patients commonly show a history of fish tank cleaning, oyster shucking, swimming, or other aquatic activities .
At two occasions skin biopsies from several lesions (dorsum of right digit IV, dorsum of the right hand, the right elbow, and the patients back) were initiated and subjected in parallel to histopathological and microbiological examinations. They revealed caseating epitheloid cell granuloma in the dermis with a marginal zone of lymphocytes and a subepidermal lymphohistiocytic infiltrate with perivascular accentuation (Figure 1E, F). By PAS-, Fite-, Ziehl-Neelsen and Auramin staining no acid fast bacilli were detected. Borrelia-specific IgM and IgG and tuberkulin skin test were negative. Microbiological cultures showed twice growth of M. haemophilum from independent lesions on the right hand taken about 8 weeks apart. Interestingly, M. kansasii was recovered from another lesion on the right elbow indicating a mixed infection.
Mycobacteria-specific liquid and solid cultures were performed by using the automated BACTEC MGIT 960 system (Becton Dickinson) at 36°C and Lowenstein-Jensen Agar (LJA) at 24°C, 30°C, and 36°C. Growth of acid fast bacilli was detected from LJA at 30°C supplemented with hemin discs. First, culture isolates were identified as NTM due to the absence of an amplicon by a M. tuberculosis-specific gyrB PCR  and were then further verified by the GenoType Mycobacterium DNA strip technology (Hain Lifescience, Nehren, Germany), namely the GenoType Mycobacterium CM and AS assay (CM, common mycobacteria; AS, additional species) . The GenoType Mycobacterium CM assay enables the simultaneous identification of several species, including those of the M. tuberculosis complex, the M. avium complex, M. abscessus, M. kansasii and M. chelonae etc. The Mycobacterium AS test provides the identification of rarely found species, such as M. simiae, M. haemophilum, and M. mucogenicum. In case of M. haemophilum, Mycobacterium CM assay revealed a banding pattern specific for the M. haemophilum-M. nebraskense-M. malmoense-M. palustre group. Further species differentiation was done with the AS assay that showed positivity for M. haemophilum and M. nebraskense but not for M. malmoense or M. palustre. The growth requirement for hemin indicated the presence of M. haemophilum. Nevertheless, species identification of M. haemophilum was confirmed at the National Reference Center for Mycobacteria in Borstel (Germany). M. kansasii was recovered with the Bactec MGIT 960 and identified with the GenoType Mycobacterium CM assay.
Thus, culture positive lesions were all from the right body site, while no co-infection of a single lesion was found. Interestingly, the patient was working as a scaffolder having potential exposure to diverse environmental habitats while touring around Europe. Further, he is aquarist but reports to usually wear gloves during cleaning his aquarium.
Interestingly, in the patient's history a selective IgA-deficiency was documented since childhood. His mother also suffered from IgA-deficiency. Since infancy human immunoglobulin (Beriglobin®) was administered, but due to his frequent travel activities the substitution was realized irregularly. Serum IgA level was 1.8 (07-4.0) mg/ml under substitution with Beriglobin®. Biochemical laboratory parameters were within normal ranges except for serum protein electrophoresis with albumin of 57.2% (59-70.6) and beta globulin of 14.9% (7.3-12.2). ASL, AST, ACE, ANA, and ENA tests were unremarkable. Besides multiple cutaneous lesions there was no evidence for lymphadenopathy or systemic infection with M. haemophilum/M. kansasii by using abdominal ultrasound, thorax X-ray, and thoraco-abdominal computer tomography imaging. Mycobacterial sputum cultures were negative as well. Empirical triple treatment with clarithromycine 2 × 500 mg/d, rifabutine 1 × 300 mg/d and ethambutol 1 × 20 mg/kg body weight/d was initiated. This regime was given for 6 months, while a complete clinical remission of skin lesions was seen within 4 months. Finally, two years after his initial presentation the patient is still healthy.
NTM can be categorized by the growth rate in slowly growing and rapidly growing species, pigmentation (pigmented and non-pigmented species), and optimal growth temperature, which can provide helpful information for a preliminary classification of NTM. M. marinum, M. kansasii, and M. avium-intracellulare are examples of slow-growing mycobacteria. M. fortuitum, M. chelonea, and M. abscessus are examples of rapidly growing mycobacteria [1, 2]. Diagnosis relies on skin biopsy, histopathologic examination, microbiological culture and molecular detection of mycobacterial DNA.
Strikingly, cutaneous M. haemophilum infections are most often the result of HIV- or transplantation-associated immunosuppression. It's most common clinical manifestations are cutaneous lesions with a preference for cooler body sites such as extremities. Therefore, in case of skin biopsies LJA at 30°C should routinely supplemented with hemin discs in order to fulfill special growth requirements of M. haemophilum that is known to primarily cause cutaneous infections. Rarely, M. haemophilum may infect iatrogenically immunosuppressed patients without transplantation or even healthy persons. The development of sporotrichoid nodular lymphangitis due to M. haemophilum is exceptional .
In contrast, M. kansasii infection has been reported in up to 20 percent of nontuberculous mycobacteriosis in both immunocompetent and immunocompromised patients. Disseminated infections are uncommon but of poor prognosis . The outcome of M. kansasii pulmonary infection is good if diagnosed and treated early. In one report, M. kansasii cutaneous infection occurred on the hand and forearm, with carpal tunnel syndrome complicated by concomitant pulmonary M. tuberculosis , and in another as cellulitis in a patient with systemic lupus erythematosus .
As the only comorbid condition our patient showed IgA-deficiency. Sustained, very low levels of IgA, IgG, or IgM, as found in primary immunodeficiency syndromes, are associated with significantly increased risk for infections, primarily respiratory tract infections of bacterial origin. IgA, a major serum Ig and the predominant antibody in external secretions that bathe mucosal surfaces, plays a key role in immune protection. IgA at concentrations of about 2-3 mg/ml is the second most prevalent serum antibody after IgG, which is normally present at about 12 mg/ml. However, IgA-deficiency is the most common primary antibody deficiency and appears to be well tolerated. Due to the large surface area of the human mucosa of up to 400 m2, the role of IgA in the protection of this surface from harmful environmental agents is extremely essential. Any changes connected with a lack or an overproduction of IgA can manifest as variable clinical disease . Most individuals with IgA-deficiency have no apparent symptoms, but selected patients suffer from recurrent mucosal infections, allergies, and autoimmune diseases . Obviously, this biological diversity has both genetic and environmental components. For instance, it is known that IgA is secreted with sweat (sIgA) assuming an important immunological function on skin. Moreover, lower cutaneous sIgA levels and increased skin infections have been reported in patients with atopic dermatitis, while these patients of course often present also an impairment of the normal skin barrier. In conclusion, there are some clues about an association of skin infections with IgA-deficiency, although no clear pathophysiological link may be provided [11–13]. Strikingly, there is increasing evidence that serum IgA is able to trigger effector functions that have the potential to destroy microorganisms and mammalian cells. It has long been recognized that compared with IgM and IgG, IgA is a poor activator of complement. IgA does not activate the classical pathway and its role in activation of the alternative pathway remains controversial . However, it may have a role in activation of phagocytic system by means of the FcRα receptors. It has been proposed that serum IgA binds to FcRα receptor on the monocytes and granulocytes; thereby, immune complexes formed by foreign antigens and IgA are cleared from the circulation by the phagocytic system without activating the complement system and without causing inflammation. Serum IgA may also have a role in controlling the immune system through inhibition of neutrophil chemotaxis by binding to other inhibitory proteins such as α-1-antitrypsin and forming complexes. Bacteria of the intestinal tract, oral cavity, and respiratory and genital tracts are coated with secretory IgA. As a result, the epithelial adherence and penetration of bacteria are limited, and the bacteria are confined to the mucosal surfaces . Rodriguez et al. suggest that IgA may play a role in protection against mycobacterial infections in the respiratory tract by blocking the pathogen entrance and/or by modulating the pro-inflammatory responses .
Most likely, in our patient NTM's are transmitted from a contaminated environmental source by a direct cutaneous route. The exact source and the infection mode remain unclear. Nevertheless, even in a healthy individual an appropriate exposition (e.g. skin injury, "high" bacterial burden) may lead to NTM infections, as described for M. marinum. In IgA-deficiency, beside reduced serum IgA levels often also other immune deficiencies e.g. in cytokine levels and B-cell function but also associated T cell defects have been described. Thus, we cannot exclude that IgA-deficiency may be a surrogate for another undetected less marked immune dysfunction .
This is the first report of a mixed cutaneous infection M. haemophilum and M. kansasii, both belonging to the slow growing mycobacteria, in a patient with IgA-deficiency. The patient is aquarist and was working as a scaffolder presenting a relevant risk of exposure to diverse environmental habitats while touring around Europe. Although according to current knowledge no definite pathophysiological link between mycobacterial disease and IgA-deficiency may be given, we cannot rule out that this immunological imbalance may contribute to the patient's vulnerability towards NTM. Finally, the patient responded well to triple anti-mycobacterial therapy with complete regression of entire skin lesions within 4 months.
We obtained a written informed consent from the patient for publication of this article and accompanying images. A copy of the written consent is available for the review by the Editor-in-Chief of this journal.
The authors would like to thank the patient for his collaboration and Elvira Richter from the German National Reference Center for Mycobacteria for the verification of M. haemophilum. The authors have no sources of financial support to disclose.
- Aghamohammadi A, Mohammadi J, Parvaneh N, Rezaei N, Moin M, Espanol T, Hammarstrom L: Progression of Selective IgA Deficiency to Common Variable Immunodeficiency. Int Arch Allergy Immunol 2008, 147(2):87–92. 10.1159/000135694View ArticlePubMedGoogle Scholar
- Tortoli E: Mycobacterium kansasii, species or complex? Biomolecular and epidemiological insights. Kekkaku 2003, 78(11):705–9.PubMedGoogle Scholar
- Bhambri S, Bhambri A, Del Rosso JQ: Atypical mycobacterial cutaneous infections. Dermatol Clin 2009, 27(1):63–73. 10.1016/j.det.2008.07.009View ArticlePubMedGoogle Scholar
- Hsu PY, Yang YH, Hsiao CH, Lee PI, Chiang BL: Mycobacterium kansasii infection presenting as cellulitis in a patient with systemic lupus erythematosus. J Formos Med Assoc 2002, 101(8):581–4.PubMedGoogle Scholar
- Razavi B, Cleveland MG: Cutaneous infection due to Mycobacterium kansasii. Diagn Microbiol Infect Dis 2000, 38(3):173–5. 10.1016/S0732-8893(00)00195-4View ArticlePubMedGoogle Scholar
- Blue ML, Payne WG, Mannari RI, Moffitt MR, Walusimbi MG, Robson MC: Mycobacterium kansasii causing carpal tunnel syndrome with concomitant pulmonary Mycobacterium tuberculosis infection. South Med J 2002, 95(9):1095–8.View ArticlePubMedGoogle Scholar
- Niemann S, Harmsen D, Rüsch-Gerdes S, Richter E: Differentiation of clinical Mycobacterium tuberculosis complex isolates by gyrB DNA sequence polymorphism analysis. J Clin Microbiol 2000, 38(9):3231–4.PubMedPubMed CentralGoogle Scholar
- Richter E, Rüsch-Gerdes S, Hillemann D: Evaluation of the Geno Type Mycobacterium Assay for identification of mycobacterial species from cultures. J Clin Microbiol 2006, 44(5):1769–75. 10.1128/JCM.44.5.1769-1775.2006View ArticlePubMedPubMed CentralGoogle Scholar
- Suzuki Y, Nozaki Y, Nakanishi K, Konoh T, Yoshimoto T, Nishiwaki K: A rare case of disseminated Mycobacterium kansasii infection. Kekkaku 2005, 80(4):359–64.PubMedGoogle Scholar
- Czyzewska-Buczyńska A, Lewandowicz-Uszyńska A, Jankowski A: IgA, an essential part of the immune system: selected issues. Postepy Hig Med Dosw (Online) 2006, 61: 38–47.Google Scholar
- Imayama S, Shimozono Y, Hoashi M, Yasumoto S, Ohta S, Yoneyama K, Hori Y: Reduced secretion of IgA to skin surface of patients with atopic dermatitis. J Allergy Clin Immunol 1994, 94(2 Pt 1):195–200. 10.1016/0091-6749(94)90040-XView ArticlePubMedGoogle Scholar
- Burrows PD, Cooper MD: IgA deficiency. Adv Immunol 1997, 65: 245–76. Review full_textView ArticlePubMedGoogle Scholar
- Bundino S, Zina AM: Pyoderma gangrenosum associated with selective hereditary IgA deficiency. Dermatologica 1984, 168(5):230–2. 10.1159/000249709View ArticlePubMedGoogle Scholar
- Woof J, Kerr M: The function of immunoglobulin A in immunity. J Pathol 2006, 208: 270–282. 10.1002/path.1877View ArticlePubMedGoogle Scholar
- Leman Yel: Selective IgA deficiency. J Clin Immunol 2010, 30: 10–16. 10.1007/s10875-009-9357-xView ArticleGoogle Scholar
- Rodriguez A, Tiärnlund A, Ivanii J, Singh M, Garcia I, Williams A, Marsh PD, Trove-Blomberg M, Fernandez C: Role of IgA in the defense against respiratory infections IgA deficient mice exhibited increased susceptibility to intranasal infection with Mycobacterium bovis BCG. Vaccine 2005, 23(20):2565–72. 10.1016/j.vaccine.2004.11.032View ArticlePubMedGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-5945/11/3/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.